{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T05:38:18Z","timestamp":1648791498959},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arzneimittelforschung"],"DOI":"10.1055\/s-0031-1296404","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T12:48:45Z","timestamp":1343738925000},"page":"327-334","source":"Crossref","is-referenced-by-count":0,"title":["Antacid Use and Reduced Bioavailability of Oral Drugs"],"prefix":"10.1055","volume":"59","author":[{"given":"Nuggehally","family":"Srinivas","sequence":"additional","affiliation":[{"name":"Integrated Drug Development"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2011,12,13]]},"container-title":["Arzneimittelforschung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0031-1296404.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T21:03:40Z","timestamp":1495487020000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0031-1296404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,13]]},"references-count":0,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2009,7]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0031-1296404","relation":{},"ISSN":["0004-4172","1616-7066"],"issn-type":[{"value":"0004-4172","type":"print"},{"value":"1616-7066","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,13]]}}}